SCHEMBL29133771

SCHEMBL29133771

N#Cc1cnc2ccc(-c3ccc4oc(N)nc4c3)cc2c1NCCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 7/20 0.46
PRKDC P78527 4/20 0.46
PIK3CA P42336 8/20 0.45
SRC P12931 3/20 0.45
ABL1 P00519 1/20 0.45
FLT1 P17948 1/20 0.45
KDR P35968 1/20 0.45
SYK P43405 1/20 0.45
CCNC P24863 2/20 0.42
CDK8 P49336 2/20 0.42
CDKN1A P38936 1/20 0.42
CDK19 Q9BWU1 1/20 0.42
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133731 0.84 EGFR (0.63) EGFRPRKDCPIK3CASRCABL1
SCHEMBL29133761 0.83 EGFR (0.51) EGFRPRKDCPIK3CASRCABL1
SCHEMBL29133717 0.82 EGFR (0.50) EGFRPRKDCPIK3CASRCABL1
SCHEMBL29133747 0.81 PIK3CA (0.65) EGFRPIK3CASRCCCNCCDK8
SCHEMBL29133710 0.80 CYP1A2 (0.52) EGFRPRKDCSRCABL1FLT1
SCHEMBL24576547 0.80 EGFR (0.73) EGFRPRKDCPIK3CASRCABL1
SCHEMBL29775122 0.80 EGFR (0.73) EGFRPRKDCPIK3CASRCABL1
SCHEMBL29133738 0.79 CCNC (0.47) EGFRPRKDCPIK3CASRCABL1
SCHEMBL29133709 0.79 EGFR (0.49) EGFRPRKDCPIK3CASRCABL1
SCHEMBL29133698 0.78 MELK (0.54) EGFRPRKDCSRCABL1FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 CN disclosed